Andres G. Grandea
Vanderbilt University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andres G. Grandea.
Immunity | 2000
Andres G. Grandea; Tatiana N. Golovina; Sara E. Hamilton; Venkataraman Sriram; Thomas Spies; Randy R. Brutkiewicz; John T. Harty; Laurence C. Eisenlohr; Luc Van Kaer
Loading of peptides onto major histocompatibility complex class I molecules involves a multifactorial complex that includes tapasin (TPN), a membrane protein that tethers empty class I glycoproteins to the transporter associated with antigen processing. To evaluate the in vivo role of TPN, we have generated Tpn mutant mice. In these animals, most class I molecules exit the endoplasmic reticulum (ER) in the absence of stably bound peptides. Consequently, mutant animals have defects in class I cell surface expression, antigen presentation, CD8+ T cell development, and immune responses. These findings reveal a critical role of TPN for ER retention of empty class I molecules. Tpn mutant animals should prove useful for studies on alternative antigen-processing pathways that involve post-ER peptide loading.
Trends in Immunology | 2001
Andres G. Grandea; Luc Van Kaer
The stable assembly of MHC class I molecules with peptides in the endoplasmic reticulum (ER) involves several accessory molecules. One of these accessory molecules is tapasin, a transmembrane protein that tethers empty class I molecules to the peptide transporter associated with antigen processing (TAP). Here, evidence is presented that tapasin retains class I molecules in the ER until they acquire high-affinity peptides.
Journal of Immunology | 2004
Leon F. Garcia-Martinez; Mark W. Appleby; Karen Staehling-Hampton; Dawn Michele Andrews; Yuching Chen; Mark McEuen; Phuong Tang; Rebecca L. Rhinehart; Sean Proll; Bryan W. Paeper; Mary E. Brunkow; Andres G. Grandea; Edward D. Howard; Don E. Walker; Patrick Charmley; Mechthild Jonas; Stevan Shaw; John Latham; Fred Ramsdell
Using a mouse mutagenesis screen, we have identified CD83 as being critical for the development of CD4+ T cells and for their function postactivation. CD11c+ dendritic cells develop and function normally in mice with a mutated CD83 gene but CD4+ T cell development is substantially reduced. Additionally, we now show that those CD4+ cells that develop in a CD83 mutant animal fail to respond normally following allogeneic stimulation. This is at least in part due to an altered cytokine expression pattern characterized by an increased production of IL-4 and IL-10 and diminished IL-2 production. Thus, in addition to its role in selection of CD4+ T cells, absence of CD83 results in the generation of cells with an altered activation and cytokine profile.
Journal of Immunology | 2003
Peter J. Chefalo; Andres G. Grandea; Luc Van Kaer; Clifford V. Harding
Alternate class I MHC (MHC-I) Ag processing via cytosolic or vacuolar pathways leads to cross-presentation of exogenous Ag to CD8 T cells. Vacuolar alternate MHC-I processing involves phagolysosomal Ag proteolysis and peptide binding to MHC-I in post-Golgi compartments. We report the first study of alternate MHC-I Ag processing in tapasin−/− cells and experiments with tapasin−/− and TAP1−/− macrophages that characterize alternate MHC-I processing. Tapasin promotes retention of MHC-I in the endoplasmic reticulum (ER) for loading with high affinity peptides, whereas tapasin−/− cells allow poorly loaded MHC-I molecules to exit the ER. Hypothetically, we considered that a large proportion of post-Golgi MHC-I on tapasin−/− cells might be peptide-receptive, enhancing alternate MHC-I processing. In contrast, alternate MHC-I processing was diminished in both tapasin−/− and TAP1−/− macrophages. Nonetheless, these cells efficiently presented exogenous peptide, suggesting a loss of MHC-I stability or function specific to vacuolar processing compartments. Tapasin−/− and TAP1−/− macrophages had decreased MHC-I stability and increased susceptibility of MHC-I to inactivation by acidic conditions (correlating with vacuolar pH). Incubation of tapasin−/− or TAP1−/− cells at 26°C decreased susceptibility of MHC-I to acid pH and reversed the deficiency in alternate MHC-I processing. Thus, tapasin and TAP are required for MHC-I to bind ER-derived stabilizing peptides to achieve the stability needed for alternate MHC-I processing via peptide exchange in acidic vacuolar processing compartments. Acidic pH destabilizes MHC-I, but also promotes peptide exchange, thereby enhancing alternate MHC-I Ag processing. These results are consistent with alternate MHC-I Ag processing mechanisms that involve binding of peptides to MHC-I within acidic vacuolar compartments.
Journal of Immunology | 2004
Li Qi Li; Barbara A. Sullivan; Carla J. Aldrich; Mark J. Soloski; James Forman; Andres G. Grandea; Peter E. Jensen; Luc Van Kaer
The loading of MHC class I molecules with peptides involves a variety of accessory proteins, including TAP-associated glycoprotein (tapasin), which tethers empty MHC class I molecules to the TAP peptide transporter. We have evaluated the role of tapasin for the assembly of peptides with the class Ib molecule Qa-1b. In normal cells, Qa-1b is predominantly bound by a peptide, the Qa-1 determinant modifier (Qdm), derived from the signal sequence of class Ia molecules. Our results show that tapasin links Qa-1b to the TAP peptide transporter, and that tapasin facilitates the delivery of Qa-1b molecules to the cell surface. Tapasin was also required for the presentation of endogenous Qdm peptides to Qdm-specific, Qa-1b-restricted CTLs. In sharp contrast, tapasin expression was dispensable for the presentation of an insulin peptide to insulin-specific, Qa-1b-restricted CTL isolated from TCR transgenic mice. However, tapasin deficiency significantly impaired the positive selection of these insulin-specific, Qa-1b-restricted transgenic CD8+ T cells. These findings reveal that tapasin plays a differential role in the loading of Qdm and insulin peptides onto Qa-1b molecules, and that tapasin is dispensable for retention of empty Qa-1b molecules in the endoplasmic reticulum, and are consistent with the proposed peptide-editing function of tapasin.
Archive | 2010
Andres G. Grandea; Gordon E. King; Thomas C. Cox; Ole Olsen; Jennifer L. Mitcham; Matthew Moyle; Phil Hammond
Archive | 2011
Ole Olsen; Christina L. Boozer; Andres G. Grandea
Archive | 2010
Po-Ying Chan-Hui; Steven Frey; Andres G. Grandea; Thomas C. Cox
Archive | 2017
Mechthild Jonas; Stevan Shaw; John Latham; Edward D. Howard; Don E. Walker; Patrick Charmley; Bryan W. Paeper; Mary E. Brunkow; Andres G. Grandea; Mark McEuen; Phuong Tang; Rebecca L. Rhinehart; Dawn Michele Andrews; Yuching Chen
Archive | 2012
Andres G. Grandea; Gordon E. King; Thomas C. Cox; Ole Olsen; Jennifer L. Mitcham; Matthew Moyle; Phil Hammond